CurrentRheuma
Get Weekly

CurrentRheuma coverage · page 37 of 48

Rheumatology (Oxford)

Briefs 1,441–1,480 of 1,905 CurrentRheuma has covered from this journal, newest publication first

Latest from Rheumatology (Oxford)

All coverage, newest first

  1. Rheumatology (Oxford)

    The COMPARE head-to-head, randomized controlled trial of SEL-212 (pegadricase plus rapamycin-containing nanoparticle, ImmTOR™) versus pegloticase for refractory gout

    Randomized controlled trialGout & crystals

  2. Rheumatology (Oxford)

    Glucocorticoid treatment in SLE is associated with infections, comorbidities and mortality—a national cohort study

    Cohort studyLupus & APS

  3. Rheumatology (Oxford)

    Presence of periodontal disease and the incidence of inflammatory arthritides in the general population: data from the UK Biobank

    Cohort studyRA

  4. Rheumatology (Oxford)

    Trends for opioid prescribing and the impact of the COVID-19 pandemic in patients with rheumatic and musculoskeletal diseases between 2006 and 2021

    Cohort studyAcross diseases

  5. Rheumatology (Oxford)

    Actigraphic and self-reported characterization of sleep in systemic lupus erythematosus patients

    Cross-sectional studyLupus & APS

  6. Rheumatology (Oxford)

    Anti-survival motor neuron complex antibodies as a novel biomarker for pulmonary arterial hypertension and interstitial lung disease in mixed connective tissue disease

    Cohort studySjögren's & overlap

  7. Rheumatology (Oxford)

    New-onset atrial fibrillation in seropositive rheumatoid arthritis: association with disease-modifying anti-rheumatic drugs treatment

    Case-control studyRA

  8. Rheumatology (Oxford)

    Performance of serum biomarkers reflective of different pathogenic processes in systemic sclerosis-associated interstitial lung disease

    Cohort studySystemic sclerosis

  9. Rheumatology (Oxford)

    Assessment of digital perfusion as a surrogate outcome in Raynaud’s phenomenon clinical trials

    Diagnostic or prognostic studySystemic sclerosis

  10. Rheumatology (Oxford)

    Temporal trends in mortality in patients with rheumatoid arthritis: a Danish population-based matched cohort study

    Cohort studyRA

  11. Rheumatology (Oxford)

    Infection incidence, timing and dose dependency in rheumatoid arthritis patients treated with rituximab: a retrospective cohort study

    Cohort studyRA

  12. Rheumatology (Oxford)

    The influence of biological DMARDs on aseptic arthroplasty loosening: a retrospective cohort study

    Cohort studyRA

  13. Rheumatology (Oxford)

    Gut microbiota alterations are associated with phenotype and genotype in familial Mediterranean fever

    Cross-sectional studyAutoinflammatory & rare

  14. Rheumatology (Oxford)

    Lung ultrasound compared to computed tomography detection and automated quantification of systemic sclerosis-associated interstitial lung disease: preliminary study

    Diagnostic or prognostic studySystemic sclerosis

  15. Rheumatology (Oxford)

    Efficacy and safety of telitacicept in primary Sjögren’s syndrome: a randomized, double-blind, placebo-controlled, phase 2 trial

    Randomized controlled trialSjögren's & overlap

  16. Rheumatology (Oxford)

    A proteomics study of rheumatoid arthritis patients on etanercept identifies putative biomarkers associated with clinical outcome measures

    Cohort studyRA

  17. Rheumatology (Oxford)

    Improving our understanding of the paradoxical protective effect of obesity on radiographic damage: a large magnetic resonance imaging-study in early arthritis

    Cohort studyRA

  18. Rheumatology (Oxford)

    Profile and clinical relevance of non-criteria antiphospholipid antibodies in patients diagnosed with or highly suspected of APS

    Cross-sectional studyLupus & APS

  19. Rheumatology (Oxford)

    Impact of interstitial lung disease on clinical remission and unfavourable events of rheumatoid arthritis: results from the IORRA cohort

    Cohort studyRA

  20. Rheumatology (Oxford)

    Characteristics and outcome of ANCA-associated vasculitides induced by anti-thyroid drugs: a multicentre retrospective case-control study

    Case-control studyVasculitis & PMR

  21. Rheumatology (Oxford)

    IL-6 inhibitors and JAK inhibitors as favourable treatment options for patients with anaemia and rheumatoid arthritis: ANSWER cohort study

    Cohort studyRA

  22. Rheumatology (Oxford)

    The predictors of paradoxical reactions, especially psoriasis, to biologic therapy—findings from the TReasure database: a 5-year follow-up study

    Case-control studySpondyloarthritis & PsA

  23. Rheumatology (Oxford)

    Discordance between patient- and physician-reported disease activity in adult idiopathic inflammatory myopathy

    Cross-sectional studyMyositis

  24. Rheumatology (Oxford)

    Prevalence of LTBI in patients with autoimmune diseases and accuracy of IGRA in predicting TB relapse

    Cross-sectional studyAcross diseases

  25. Rheumatology (Oxford)

    Identification of CD64 as a marker for the destructive potential of synovitis in osteoarthritis

    Mechanistic studyOsteoarthritis

  26. Rheumatology (Oxford)

    Neuropsychiatric lupus in late- and early-onset systemic lupus erythematosus patients: a systematic review and meta-analysis

    Meta-analysisLupus & APS

  27. Rheumatology (Oxford)

    Platelet TLR7 is essential for the formation of platelet–neutrophil complexes and low-density neutrophils in lupus nephritis

    Mechanistic studyLupus & APS

  28. Rheumatology (Oxford)

    The comparative performance of three screening questionnaires for psoriatic arthritis in a primary care surveillance study

    Diagnostic or prognostic studySpondyloarthritis & PsA

  29. Rheumatology (Oxford)

    Lupus activity and outcomes in lupus patients undergoing maintenance dialysis

    Cohort studyLupus & APS

  30. Rheumatology (Oxford)

    Acute calcium pyrophosphate crystal arthritis is associated with an increased rate of hip and knee joint surgery

    Cohort studyGout & crystals

  31. Rheumatology (Oxford)

    Subtherapeutic hydroxychloroquine concentration is associated with increased disease activity and greater organ damage in lupus

    Cohort studyLupus & APS

  32. Rheumatology (Oxford)

    Systemic pharmacological treatment of digital ulcers in systemic sclerosis: a systematic literature review

    Cohort studySystemic sclerosis

  33. Rheumatology (Oxford)

    Genome-wide investigation of persistence with methotrexate treatment in early rheumatoid arthritis

    Diagnostic or prognostic studyRA

  34. Rheumatology (Oxford)

    Azathioprine vs methotrexate in eosinophilic granulomatosis with polyangiitis: a monocentric retrospective study

    Cohort studyVasculitis & PMR

  35. Rheumatology (Oxford)

    Belimumab treatment of adult idiopathic inflammatory myopathy

    Randomized controlled trialMyositis

  36. Rheumatology (Oxford)

    Predictors of DAPSA28 remission in patients with psoriatic arthritis initiating a first TNF inhibitor: results from 13 European registries

    Diagnostic or prognostic studySpondyloarthritis & PsA

  37. Rheumatology (Oxford)

    Joint tenderness at 3 months follow-up better predicts long-term pain than baseline characteristics in early rheumatoid arthritis patients

    Cohort studyRA

  38. Rheumatology (Oxford)

    Increased CD8+ tissue resident memory T cells, regulatory T cells and activated natural killer cells in systemic sclerosis lungs

    Mechanistic studySystemic sclerosis

  39. Rheumatology (Oxford)

    Damage measured by Damage Index for Antiphospholipid Syndrome (DIAPS) in antiphospholipid antibody-positive patients included in the APS ACTION registry

    Cross-sectional studyLupus & APS

  40. Rheumatology (Oxford)

    Solid validity evidence for two tools assessing competences in musculoskeletal ultrasound: a validity study

    Research articleRA

All 1,905 Briefs in ExploreShowing Briefs 1,441–1,480 of 1,905, newest first